By-Health Co., Ltd., founded in 1995 and headquartered in Zhuhai, Guangdong province, is China's largest dietary supplement and health food company, commanding a leading position in the domestic vitamins and dietary supplements (VDS) market. The company's product portfolio spans protein powders, vitamin and mineral supplements, probiotics, omega-3 fish oils, herbal extracts, and specialized nutritional products targeting specific health concerns from bone and joint health to immune support and cardiovascular wellness. By-Health operates a unique "transparent factory" concept, where its manufacturing facilities are open to consumer visits, reinforcing brand trust through radical production transparency—a pioneering approach in China's food and health product industry. The company has been listed on the Shenzhen Stock Exchange's ChiNext board since 2010.

By-Health's competitive moat is its unparalleled supply chain integration, sourcing premium raw materials from 23 countries through direct partnerships with leading global ingredient suppliers, ensuring both quality differentiation and cost control. The company's scientific credibility is reinforced by its collaborations with research institutions and clinical validation studies that substantiate product efficacy claims—an uncommon practice in the broader supplement industry. In 2025, By-Health published its ESG report detailing its responsible sourcing framework, including commitments to traceability for all botanical ingredients and sustainable harvesting practices for marine-derived raw materials. The company also expanded its "Nutrition for the Future" public health program, providing free nutritional supplements and health education to schoolchildren in rural western China, reaching over 500,000 beneficiaries since the program's inception.

汤臣倍健股份有限公司成立于1995年，总部位于广东珠海，是中国最大的膳食补充剂和健康食品公司，在国内维生素和膳食补充剂（VDS）市场占据领先地位。公司产品组合涵盖蛋白粉、维生素和矿物质补充剂、益生菌、欧米伽-3鱼油、草本提取物以及针对特定健康需求的专用营养产品，从骨骼关节健康到免疫支持和心血管保健。汤臣倍健运营着独特的「透明工厂」概念，其生产设施向消费者开放参观，通过极致的生产透明度强化品牌信任——这是中国食品和保健品行业的开创性做法。公司自2010年起在深交所创业板上市。

汤臣倍健的竞争护城河在于其无与伦比的供应链整合，通过与全球领先原料供应商的直接合作，从23个国家采购优质原材料，确保了品质差异化和成本控制。公司的科学公信力通过与研究机构的合作和证实产品功效声明的临床验证研究得到加强——这在广泛的补充剂行业中并不常见。2025年，汤臣倍健发布了ESG报告，详细阐述了其负责任采购框架，包括对所有植物原料的追溯承诺和海洋来源原材料的可持续采收实践。公司还扩展了「营养未来」公共卫生计划，为中国西部农村学童提供免费营养补充剂和健康教育，自计划启动以来已惠及超过50万名受益者。